Success Story: From RFE to Approval: NIW Win for A Chinese Manager of Biostatistics Thanks to Our Expert Team

Client’s Testimonial:

“Thank you very much for preparing the NIW case for me with patience and professionalism. I really appreciate it. Will recommend to my friends if they need similar services.”

On April 22^nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Manager of Biostatistics in the Field of Biostatistics (Approval Notice).

General Field: Biostatistics

Position at the Time of Case Filing: Manager of Biostatistics

Country of Origin: China

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: April 22^nd, 2025

Processing Time: 21 months, 25 days

Case Summary:

We are pleased to share the approval of a National Interest Waiver (NIW) petition filed for a PhD holder whose work lies at the intersection of biomedical data analysis, clinical trials, and public health. The petition was approved in April 2025, following a successful response to a Request for Evidence (RFE).

The client’s proposed endeavor focuses on analyzing biomedical and clinical data to advance drug development and data-driven medical decisions. Their work supports the design of clinical trials and statistical frameworks that inform therapeutic strategies for serious health challenges such as cancer and oral disease. The broader goal of this research is to optimize treatment outcomes, enhance public health interventions, and reduce disease burden through innovative biostatistical methods.

At the time of filing, the client was employed in the pharmaceutical sector as a biostatistics manager, contributing to projects that improve clinical trial efficacy and help shape drug development strategies. Their research efforts include statistical model development, outcome analysis, and experimental design, with a focus on real-world applications.

To date, the client has authored 15 peer-reviewed journal articles, including 2 first-authored papers. Their work has been cited 82 times, and they have served as a reviewer for esteemed journals in the field, completing at least 2 peer reviews. Several of their publications are among the most highly cited in Clinical Medicine for their publication years, highlighting the impact and influence of their work within the scientific community.

The NIW petition emphasized the national relevance of the client’s contributions, citing research that has advanced understanding in areas such as oral microbiota development, osteoporosis-related jaw bone changes, and treatment optimization frameworks in clinical medicine. Their findings have been incorporated into studies around the world and funded by major U.S. public health institutions, underscoring their practical utility and alignment with national healthcare goals.

The petition included 4 letters of recommendation from field experts, including several independent references.

“His unique perspective, phenomenal credentials, and innovative research have enabled him to drive biostatistics forward to the benefit of not just his fellow researchers, but the healthcare system at large.”

This approval reflects the importance of biostatistical innovation in shaping the future of evidence-based healthcare. We are proud to have helped secure a successful outcome for this researcher and look forward to their continued contributions to medical data science and public health advancement.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.